Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.5.2021Laboratoires THEA (LHH-1)7895CMYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injekčný roztok (sol inj 20x0,6 ml (amp.skl.hnedá+20 ihiel v blis.papier/PVC))11.5.2021O
 11.5.2021Laboratoires THEA (LHH-1)7895CMYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injekčný roztok (sol inj 20x0,6 ml (amp.skl.hnedá+20 ihiel v blis.papier/PVC))11.5.2021R
 11.5.2021Viatris Healthcare Limited (VIM-1)43229Gopten 2 mg (cps 98x2 mg (blis.PVC/PVDC/Al))17.5.2021R
 11.5.2021Mylan Ireland Limited (MNY)5796CSeizpat 50 mg (tbl flm 56x50 mg (blis.PVC/PVDC/Al))31.5.2021Z
 11.5.2021Merck Sharp & Dohme B.V. (MSD-NL)47435INVANZ 1 g prášok na koncentrát na infúzny roztok (plc ifc 1x1 g (liek.skl.))10.5.2021O
 11.5.2021Merck Sharp & Dohme B.V. (MSD-NL)51551Esmeron (sol inj 10x5 ml (liek.inj.skl.))10.5.2021O
 11.5.2021N.V. Organon (ORG-NL)05878Montelukast Organon 10 mg (tbl flm 56x10 mg (blis.Al/Al))10.5.2021O
 11.5.2021G.L. Pharma GmbH (GLH-2)6105BDulasolan 60 mg tvrdé gastrorezistentné kapsuly (cps end 30x60 mg (blis.PVC/PCTFE/Al))10.5.2021O
 10.5.2021Accord Healthcare Polska Sp. z o.o. (AOK)20074Epirubicin Accord 2 mg/ml (sol ijf 1x5 ml/10 mg (liek.inj.skl.s bielym viečkom))11.5.2021O
 10.5.2021Mylan Ireland Limited (MNY)52924Betahistin Mylan 16 mg (tbl 60x16 mg)31.5.2021Z
 10.5.2021Mylan Ireland Limited (MNY)8834BAmoxicillin/Clavulanic Acid Mylan 875 mg/125 mg filmom obalené tablety (tbl flm 14x875 mg/125 mg (blis.OPA/Al/PVC/Al))31.5.2021Z
 10.5.2021GlaxoSmithKline Biologicals S.A. (GAG)52849Rotarix perorálna suspenzia v stlačiteľnej tube (sus por 1x1,5 ml ( stlačiteľná PE tuba))11.6.2021R
 10.5.2021GlaxoSmithKline Biologicals S.A. (GAG)28654Priorix (plv isl 10x0,5 ml+10x0,5 ml solv. (liek.inj.skl.+striek.inj.skl.napl.s 2 oddel.ihlami))16.6.2021R
 10.5.2021GlaxoSmithKline Trading Services Limited (GAG-IRL-3)3798AZENTEL 400 mg (tbl 1x400 mg (blis.PVDC/PVC/Al))10.5.2021R
 10.5.2021Berlin-Chemie AG (BCE)46957L-Thyroxin 125 Berlin-Chemie (tbl 100)10.5.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)